CRMD
CorMedix Inc.
$8.42
-$0.04(-0.47%)
55
Overall
80
Value
50
Tech
36
Quality
Market Cap
$805.46M
Volume
1.29M
52W Range
$6.13 - $17.43
Target Price
$15.00
Company Overview
| Mkt Cap | $805.46M | Price | $8.42 |
| Volume | 1.29M | Change | -0.47% |
| P/E Ratio | 4.9 | Open | $8.43 |
| Revenue | $311.7M | Prev Close | $8.46 |
| Net Income | $163.1M | 52W Range | $6.13 - $17.43 |
| Div Yield | N/A | Target | $15.00 |
| Overall | 55 | Value | 80 |
| Quality | 36 | Technical | 50 |
No chart data available
About CorMedix Inc.
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
Sector: Healthcare
Industry: Biotechnology
Latest News
Analysts Offer Insights on Healthcare Companies: Damora Therapeutics (DMRA), Cormedix (CRMD) and AnaptysBio (ANAB)
Christine Brown•13 days ago
Analysts Offer Insights on Healthcare Companies: Keros Therapeutics (KROS), Cormedix (CRMD) and Biogen (BIIB)
Howard Kim•13 days ago
Analysts Offer Insights on Healthcare Companies: Immatics (IMTX) and Cormedix (CRMD)
Christine Brown•14 days ago
3 Low P/E Stocks with Over 40% Upside
Kirti Tak•14 days ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CRMD | $8.42 | -0.5% | 1.29M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |